Differences in contributing factors to tuberculosis incidence in US-born and foreign-born persons

被引:126
作者
Chin, DP
DeRiemer, K
Small, PM
de Leon, AP
Steinhart, R
Schecter, GF
Daley, CL
Moss, AR
Paz, EA
Jasmer, RM
Agasino, CB
Hopewell, PC
机构
[1] San Francisco Gen Hosp, Ctr Med, Div Pulm & Crit Care Med, San Francisco, CA 94110 USA
[2] San Francisco Gen Hosp, Dept Biostat & Epidemiol, San Francisco, CA 94110 USA
[3] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[4] Univ Calif Berkeley, Sch Publ Hlth, Div Publ Hlth Biol & Epidemiol, Berkeley, CA 94720 USA
[5] Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA
关键词
D O I
10.1164/ajrccm.158.6.9804029
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
To determine the factors contributing to tuberculosis incidence in the U.S.-born and foreign-born populations in San Francisco, California, and to assess the effectiveness of tuberculosis control efforts in these populations, we performed a population-based molecular epidemiologic study using 367 patients with strains of Mycobacterium tuberculosis recently introduced into the city. IS6110-based and PGRS-based restriction fragment length polymorphism (RFLP) analyses were performed on M. tuberculosis isolates. Patients whose isolates had identical RFLP patterns were considered a cluster. Review of public health and medical records, plus patient interviews, were used to determine the likelihood of transmission between clustered patients. None of the 252 foreign-born cases was recently infected (within 2 yr) in the city. Nineteen (17%) of 115 U.S.-born cases occurred after recent infection in the city; only two were infected by a foreign-born patient. Disease from recent infection in the city involved either a source or a secondary case with human immunodeficiency virus (HIV) infection, homelessness, or drug abuse. Failure to identify contacts accounted for the majority of secondary cases. In San Francisco, disease from recent transmission of M. tuberculosis has been virtually eliminated from the foreign-born but not from the U.S.-born population. An intensification of contact tracing and screening activities among HIV-infected, homeless, and drug-abusing persons is needed to further control tuberculosis in the U.S.-born population. Elimination of tuberculosis in both the foreign-born and the U.S.-born populations will require widespread use of preventive therapy.
引用
收藏
页码:1797 / 1803
页数:7
相关论文
共 35 条
[1]  
[Anonymous], 1990, MMWR Recomm Rep, V39, P1
[2]  
ASHLEY MJ, 1974, AM REV RESPIR DIS, V110, P137
[3]   Tuberculosis transmission in central Los Angeles [J].
Barnes, PF ;
Yang, ZH ;
PrestonMartin, S ;
Pogoda, JM ;
Jones, BE ;
Otaya, M ;
Eisenach, KD ;
Knowles, L ;
Harvey, S ;
Cave, MD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (14) :1159-1163
[4]   Transmission of tuberculosis among the urban homeless [J].
Barnes, PF ;
ElHajj, H ;
PrestonMartin, S ;
Cave, MD ;
Jones, BE ;
Otaya, M ;
Pogoda, J ;
Eisenach, KD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (04) :305-307
[5]   TREATMENT OF TUBERCULOSIS AND TUBERCULOSIS INFECTION IN ADULTS AND CHILDREN [J].
BASS, JB ;
FARER, LS ;
HOPEWELL, PC ;
OBRIEN, R ;
JACOBS, RF ;
RUBEN, F ;
SNIDER, DE ;
THORNTON, G .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (05) :1359-1374
[6]   RESURGENT TUBERCULOSIS IN NEW-YORK-CITY - HUMAN-IMMUNODEFICIENCY-VIRUS, HOMELESSNESS, AND THE DECLINE OF TUBERCULOSIS-CONTROL PROGRAMS [J].
BRUDNEY, K ;
DOBKIN, J .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (04) :745-749
[7]   DNA fingerprinting with two probes decreases clustering of Mycobacterium tuberculosis [J].
Burman, WJ ;
Reves, RR ;
Hawkes, AP ;
Rietmeijer, CA ;
Yang, ZH ;
ElHajj, H ;
Bates, JH ;
Cave, MD .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (03) :1140-1146
[8]   HEALTH-STATUS OF REFUGEES FROM VIETNAM, LAOS, AND CAMBODIA [J].
CATANZARO, A ;
MOSER, RJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 247 (09) :1303-1308
[9]  
Cayla JA, 1996, AIDS, V10, P1446, DOI 10.1097/00002030-199610000-00029
[10]  
*CDC, 1997, MMWR-MORBID MORTAL W, V46, P695